Company news
Pulse Biosciences, Inc news in 2022
Pulse Biosciences, Inc's news releases, calls and decks from 2022, newest first.
Pulse Biosciences Reports Third Quarter 2022 Financial Results
November 9, 2022
Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022
October 26, 2022
Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions
October 5, 2022
Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia
September 25, 2022
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
September 19, 2022
Pulse Biosciences Reports Second Quarter 2022 Financial Results
August 9, 2022
Pulse Biosciences Receives FDA 510(k) Clearance of Expanded Energy Settings for use with the CellFX® System
August 3, 2022
Pulse Biosciences Schedules Second Quarter 2022 Financial Results Conference Call for August 10, 2022
July 26, 2022
Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering
June 8, 2022
Pulse Biosciences, Inc. Announces Changes to its Rights Offering
May 18, 2022
Pulse Biosciences Reports First Quarter 2022 Financial Results
May 10, 2022
Pulse Biosciences Schedules First Quarter 2022 Financial Results Conference Call for May 11, 2022
April 27, 2022
Pulse Biosciences to Present New Data on Nano-Pulse Stimulation Procedure for Sebaceous Hyperplasia and for Focal Epithelial Hyperplasia at 2022 American Society of Laser Medicine and Surgery Annual Conference
April 25, 2022
Pulse Biosciences, Inc. Announces Rights Offering
April 13, 2022
Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results
March 30, 2022
Pulse Biosciences Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call for March 31, 2022
March 20, 2022
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
February 14, 2022
Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
February 7, 2022
Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 31, 2022
Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results
January 10, 2022
Calls in 2022
- Pulse Biosciences (NASDAQ:PLSE) Q3 2022 Earnings Call
Nov 10, 2022
Transcript - Pulse Biosciences (NASDAQ:PLSE) Q2 2022 Earnings Call
Aug 10, 2022
Transcript - Pulse Biosciences (NASDAQ:PLSE) Q1 2022 Earnings Call
May 11, 2022
Transcript - Pulse Biosciences (NASDAQ:PLSE) Q4 2021 Earnings Call
Mar 31, 2022
Transcript